We've launched a new health and safety consultancy offering that helps organisations to better manage risk and prevent workplace incidents.
Read moreThe call for effective regulation of non-surgical cosmetic procedures
Non-surgical cosmetic procedures are gaining significant popularity, with dermal fillers being one of the most sought-after treatments.
While the obvious benefit of a non-surgical procedure is that patients avoid going ‘under the knife’, the surge in body image dissatisfaction has created a vacant space for market growth, which currently lacks substantial regulation.
Here, we explore the state of patient safety in the cosmetics industry and outlines the various regulatory measures being considered by the UK Government.
Troubling statistics
In February 2022, the Department of Health and Social Care Committee (HSCC) issued a report on the impact of body image and mental and physical health. This recommended the introduction of a regulatory regime for non-surgical cosmetic procedures.
Notably, the findings revealed that:
- 8% of adults (4% of men and 13% of women) had contemplated undergoing cosmetic procedures.
- 36% of young individuals expressed a strong willingness to do 'whatever it took' to enhance their appearance. 10% of those admitted to considering cosmetic procedures.
- 5% to 15% of patients seeking cosmetic procedures met the diagnostic criteria for Body Dysmorphic Disorder.
Furthermore, in its evidence to the HSCC, the Joint Council for Cosmetic Practitioners (JCCP) — the self-regulator for the non-surgical aesthetics industry — reported that, of those who sought non-surgical procedures:
- 22% did not have any pre-treatment consultation.
- 70% had a consultation that lasted less than 20 minutes.
- Almost one in four were not asked anything about their previous medical history during their consultation.
- Almost four out of five patients were not asked anything about body image or psychological/emotional challenges during their consultation.
More recently, the UK’s largest academic survey on the complications arising from Botulinum Toxin (Botox) was conducted. Comprising of 511 participants who underwent treatment between 1999 and 2023, the Skin Health and Disease journal reported that:
- 84% of respondents did not know who regulated the aesthetics industry.
- 79% reported an adverse event, which included anxiety, pain, panic attacks and depression/low mood.
- 80.9% of practitioners were healthcare professionals, 13.8% were beauticians and the remainder was classified as either ‘unknown’ or 'other'.
- The most common administration years were 2022 at 33.2% and 2023 at 16.3%.
- 78.4% of practitioners refused to support patients when complications occurred following the procedure.
Such high figures further indicate the likelihood of new regulatory measures being introduced in the name of patient safety.
What new measures are being considered?
Within its response to the HSCC report, the Government stated that it is committed to patient safety measures and willing to focus efforts on safeguarding individuals from potential harm.
Some of these measures include:
Aesthetics licensing plan
The Government agrees with the HSCC's recommendation for a licensing regime for non-surgical cosmetic procedures. In April 2022, the Health and Care Act gave the Secretary of State for Health and Social Care the power to introduce a licensing regime. With details yet to be released, there is no immediate requirement for licenses until further consultations are held.
Two-part consent process and mental health screening
In response to the potential risks faced by vulnerable groups, the Government is considering a proposal for a two-part consent process. This would involve a full medical and mental health history and a mandatory 48-hour cooling-off period between consent and the procedure processes.
The HSCC had called for mandatory mental health screening to be included in the education and training framework for practitioners. In that regard, Professor David Sines of JCCP said “there should be no assessment without psychological and emotional assessment and safety nets must be built into the context of the pre-treatment, the treatment and the post-treatment plan for aftercare”.
Premises standards
Currently, there are no specific premises standards for beauty salons and non-CQC (Care Quality Commission) registered premises that provide non-surgical cosmetic procedures.
The Government acknowledges the need for premises standards but is mindful of duplicating existing inspection regimes. As such, it plans to liaise with the CQC to ensure that any “new premises standards operate consistently with regulatory frameworks already in place”.
Minimum standards of education, training and qualification
The government agrees with the HSCC’s recommendation for a minimum standard to be met in respect of the education, training and qualification of individuals who perform non-surgical cosmetic procedures.
The JCCP has already commenced drafting a competency framework that covers high-risk non-surgical cosmetic procedures. In addition to several Ofqual-approved qualifications, the government has stated that it will continue to work with JCCP and other stakeholders to identify further requirements.
Prescription-only dermal fillers
The HSCC’s recommendation that dermal fillers should become POMs (prescription-only medicines) has been reviewed.
The Government’s response is that dermal fillers are currently treated as medical devices. However, the Medicines and Healthcare Products Regulatory Agency (MHRA) intends to introduce more stringent rules for certain aesthetic and non-medical products (including dermal fillers) under the Medical Devices Regulations 2002. As such, there are no current plans to categorise dermal fillers as POMs.
Culture of responsibility
It’s certainly encouraging to see that a culture of responsibility and transparency is being promoted in the beauty industry. The changes will inevitably impact all practitioners and salons involved in cosmetic work, though the finer details of the Government’s proposed plans are yet to be released.
Related insights
Our health and safety law team shares guidance on how to best manage the risk of fire in care homes in compliance with the relevant regulations.
Read moreWhile medical devices could be set to completely transform the future of healthcare, the medicines and healthcare products regulatory agency (MHRA) is proposing legislative changes to ensure that new technologies are as safe as possible before hitting the UK market.
Read more